Dr. Gail Nunlee-Bland, MD

Dr. Nunlee-Bland practices at Howard University Hospital in Washington, District of Columbia, part of Howard University.

Dr. Nunlee-Bland's NPI, 1497788400, was assigned on July 10, 2006. Dr. Nunlee-Bland graduated from Howard University College of Medicine in 1980. Dr. Nunlee-Bland holds District of Columbia license MD13721.

Dr. Nunlee-Bland's primary practice is Howard University Hospital, at 2041 Georgia Ave NW, Washington, DC 20060 in The District County. The practice phone is (202) 745-6100.

Dr. Nunlee-Bland's primary practice is Howard University Hospital in Washington, District of Columbia, part of Howard University. The medical group on file is Howard University Faculty Practice Plan. Dmand AI also links Dr. Nunlee-Bland to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nunlee-Bland practices, 2 sites in all. Vendor and product names are available with a free account.

Pediatric endocrinology is Dr. Nunlee-Bland's primary specialty in the NPI Registry, under taxonomy code 2080P0205X. Dr. Nunlee-Bland is licensed in District of Columbia.

CMS data shows 196 Medicare services from Dr. Nunlee-Bland across 4 procedure codes in 2024, for 111 Medicare patients. Medicare paid $14,274 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Dr. Nunlee-Bland in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have diabetes, and 75% have high blood pressure. 62% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nunlee-Bland's median patient age at 51, with 68% women.

In 2024, Dr. Nunlee-Bland wrote 748 Medicare Part D claims for 95 patients. 49% of them were for generic drugs. CMS names the drug for 505 of them, across 21 drugs with 11 or more claims each, at $218,960 in total drug cost. In 2023, CMS named 323 claims across 15 drugs.

Dr. Nunlee-Bland accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nunlee-Bland as offering telehealth.

CMS Open Payments shows 488 general payments to Dr. Nunlee-Bland from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Corcept Therapeutics paid the most, $1,769.

Dr. Nunlee-Bland graduated from Howard University College of Medicine in 1980.